Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Chorionic Gonadotropin Market In 2029?
The market for chorionic gonadotropin has been steadily expanding over the past few years. Its size is poised to increase from $1,260 million in 2024 to $1,340 million in 2025, with a compound annual growth rate (CAGR) of 4.4%. The historic period of growth is largely due to factors such as heightened awareness of hCG among healthcare professionals and patients, its increased use in treating hormonal imbalance disorders, more affordability, improvements in healthcare facilities and a rising demand for assisted reproduction.
What Growth Rate Is Forecasted for the Chorionic Gonadotropin Market by 2029?
Anticipations are set for the chorionic gonadotropin market to experience consistent growth in the coming years, reaching a value of $1,710 million in 2029 with a 4% compound annual growth rate (CAGR). The predicted growth in the coming period can be ascribed to a surge in infertility problems, enhanced consciousness about reproductive health, and an increased usage of assisted reproductive technologies. The rise in hypogonadism prevalence among senior citizens and development in the healthcare infrastructure also contributes to this growth. Various significant trends for the forecast period encompass technological progress, advancements in recombinant technology, rise in assisted reproductive technology, continual investments in research and development, and transformative innovations in drug delivery systems and formulations.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19888&type=smp
Which Key Companies Are Shaping the Future of the Chorionic Gonadotropin Market?
Major companies operating in the chorionic gonadotropin market include Ferring Pharmaceuticals
Which Factors Are Driving Demand in the Chorionic Gonadotropin Industry?
The escalating occurrence of infertility problems is anticipated to fuel the development of the chorionic gonadotropin market in the future. Infertility implies the incapability to bear a child following one year of consistent, unprotected sex for duos under 35 years old and after half a year for duos that fall within the age group of 35 years and above. Primarily, the increased occurrence of infertility can be attributed to delayed childbearing, as numerous people opt to start families at a later life stage, and lifestyle influences like obesity and smoking, which can detrimentally affect reproductive health. Chorionic Gonadotropin (hCG) is utilized in fertility treatments to stimulate ovulation in females, support the luteal phase for sustaining pregnancy, and promote testosterone production in males in order to enhance sperm count, dealing with various infertility issues. For instance, back in April 2023, as per the World Health Organization (WHO), a specialized agency based in Switzerland, nearly 17.5% of the adult population, or 1 of every 6 people globally, suffer from infertility, highlighting the pressing requirement to enhance access to reasonable, high-quality fertility healthcare for those hurt by it. Therefore, the escalating occurrence of infertility issues is fueling the development of the chorionic gonadotropin market. A surge in assisted reproductive technologies is anticipated to fuel the development of the chorionic gonadotropin market in the future. Assisted reproductive technologies (ART) allude to medical measures used to assist individuals or couples attain pregnancy when they are incapable of doing it naturally. The surge in assisted reproductive technologies (ART) is attributed to amplified infertility rates, advancements in medicine, delayed childbearing, and increased accessibility. Chorionic gonadotropin (hCG) is utilized in assisted reproductive technologies to stimulate ovulation and support the luteal phase post-embryo transfer to ensure successful fertilization and early pregnancy. For instance, back in April 2024, as per MJH Life Sciences, a provider of trusted information for healthcare professionals based in the US, the count of ART cycles performed saw growth, with egg freezing cycles surging from 24,560 in 2021 to 29,803 in 2022. Therefore, the surge in assisted reproductive technologies is fueling the development of the chorionic gonadotropin market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=19888&type=smp
How Is the Chorionic Gonadotropin Market Segmented by Several Divisions?
The chorionic gonadotropinmarket covered in this report is segmented –
1) By Type: Human Chorionic Gonadotropin; Animal Chorionic Gonadotropin
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By Therapeutic Application: Male Hypogonadism; Female Infertility Treatment; Oligospermic Treatment; Cryptorchidism Treatment; Chronic Pain; Other Therapeutic Applications
4) By End User: Research Institutions; Pharmaceutical Companies
What are the Emerging Market Trends Driving the Growth of the Chorionic Gonadotropin Industry?
The prevailing trend in the market for chorionic gonadotropin is the emphasis on creating groundbreaking solutions like saliva-based pregnancy tests that heighten convenience, precision, and accessibility. Saliva-based pregnancy tests constitute a non-invasive diagnostic means that interprets the female saliva to discern the presence of human chorionic gonadotropin (hCG), a hormone produced in pregnancy. For illustration, Salignostics, a biotech firm based in Israel, unveiled the first-ever saliva-based pregnancy test globally in June 2023. This novel product enables females to confirm pregnancy using a saliva sample, not urine, detecting the hCG hormone within 5 to 15 minutes. Salistick delivers a more agreeable and convenient testing process, allowing for testing anywhere, and facilitating the sharing of the moment with partners or close ones.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/chorionic-gonadotropin-global-market-report
Which Regions Are Driving Growth in the Chorionic Gonadotropin Market?
North America was the largest region in the chorionic gonadotropin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19888
This Report Delivers Insight On:
1. How big is the chorionic gonadotropin market, and how is it changing globally?
2. Who are the major companies in the chorionic gonadotropin market, and how are they performing?
3. What are the key opportunities and risks in the chorionic gonadotropin market right now?
4. Which products or customer segments are growing the most in the chorionic gonadotropin market?
5. What factors are helping or slowing down the growth of the chorionic gonadotropin market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model